ExecEdge – Page 2

Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication

Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication

By Thomas S. Green Apollomics Inc. (Nasdaq: APLM) said it saw strong results from two clinical trials for Vebreltinib, designed to target non-small cell lung...

Duckhorn Portfolio 1Q Net Income at High End of Expectations

Duckhorn Portfolio 1Q Net Income at High End of Expectations

Vince Holding 3Q Profit Climbs on Cost Savings Program

Vince Holding 3Q Profit Climbs on Cost Savings Program

Octave Bioscience Announces New CEO, Board Chairman

Chinese Technology and Potential of Infiltrating Connected Devices

Chinese Technology and Potential of Infiltrating Connected Devices

Sustainable Solutions from Collagen to Tory Burch: Hear from Modern Meadow CEO, Live From NYSE Floor

Sustainable Solutions from Collagen to Tory Burch: Hear from Modern Meadow CEO, Live From NYSE Floor

AvePoint Completes Acquisition of tyGraph to Accelerate Digital Workplace Success

AvePoint Completes Acquisition of tyGraph to Accelerate Digital Workplace Success

Amer Deeba and Ravi Ithal’s Normalyze Sets the Stage for Securing Data in the Cloud

Amer Deeba and Ravi Ithal’s Normalyze Sets the Stage for Securing Data in the Cloud

Grove Collaborative Holdings Issues FY23 Guidance

Grove Collaborative Holdings Issues FY23 Guidance

Portillo’s First Quarter Revenue Climbs 16% on New Restaurants

Portillo’s First Quarter Revenue Climbs 16% on New Restaurants

Promontory Therapeutics Gives Results on Cancer Treatment Candidate PT-112

Promontory Therapeutics Gives Results on Cancer Treatment Candidate PT-112

Input your search keywords and press Enter.